The Prevalence of High Carcinogenic Risk of HPV Genotypes among HIV-Positive and HIV-Negative MSM from Russia

被引:5
|
作者
Beliakov, Ilia [1 ]
Senina, Maria [1 ]
Tyulenev, Yuriy [2 ]
Novoselova, Elena [1 ]
Surovtsev, Viktor [3 ]
Guschin, Alexander [4 ]
机构
[1] NextBio Ltd Co, Moscow 111394, Russia
[2] InterLabService Ltd, Moscow 115035, Russia
[3] RUDN Univ, Moscow 117198, Russia
[4] Moscow Sci & Pract Ctr Dermatovenerol & Cosmetol, Moscow 119071, Russia
关键词
HUMAN-PAPILLOMAVIRUS VACCINATION; INFECTED MEN; SEX; CANCER; PREDICTORS;
D O I
10.1155/2021/6641888
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective. Men who have sex with men (MSM) have a high risk of lifelong anal cancer caused by high-risk human papillomavirus (HR HPV) infections. The aim of this study was to investigate the prevalence of anal canal HR HPV infection among men who have sex with men (MSM) with and without HIV infection in Moscow (Russia). We evaluated associations of some HIV coinfections (HSV and CMV) and HPV distribution among MSM with and without HIV infection. Methods. Two groups of HIV-positive (n = 60) and HIV-negative (n = 60) MSM were evaluated in the study. Fourteen high-risk (HR) HPV types, HSV1/2, and CMV were investigated in men anal swabs. Results. HR HPVs were found with nearly the same frequency of 66.7% in both groups: HIV-positive and HIV-negative MSM. HIV-positive status was statistically associated with the presence of several (more than two) HPV types (p = 0.044). The most prevalent HR HPV genotypes were HPV18, HPV16, HPV56, and HPV33 for HIV-positive MSM and HPV56, HPV51, HPV66, and HPV16 for HIV-negatives. We found a statistically significant association of five HR HPV types with HIV status of MSM: HPV16 (p = 0.028), HPV18 (p = 0.00006), HPV58 (p = 0.003), HPV33 (p = 0.019), and HPV39 (p = 0.026). The frequency of HSV1 (1.7%) and HSV2 (10%) infections and CMV (3.3%) infection was evaluated in the group of HIV-positive MSM. The frequency of HSV1 (5%) and HSV2 (6.7%) infections and CMV (0%) infection was evaluated, as well, in the group of HIV-negative MSM. Conclusion. Multiple HPV genotypes were detected significantly more often than single HPV genotype in the group of HIV-positive MSM. According to our data, 25% of HIV-positive MSM have HPV39; this is the only one of the five types of HR HPV (16, 18, 58, 33, and 39) associated with this group of MSM that has not yet been included in the HPV vaccines available on the market.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM
    Lockart, Ian
    Matthews, Gail V.
    Danta, Mark
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (01) : 31 - 37
  • [32] Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV-negative women
    Torrisi, A
    Del Mistro, A
    Onnis, GL
    Merlin, F
    Bertorelle, R
    Minucci, D
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (02) : 168 - 172
  • [33] A comparative analysis of molecular genotypes of Mycobacterium tuberculosis isolates from HIV-positive and HIV-negative patients
    Singh, Jitendra
    Singh, Niti
    Suresh, Gayatri
    Srivastava, Rahul
    Aggarwal, Upasna
    Behera, Digamber
    Munisamy, Murali
    Malhotra, Anvita Gupta
    Singh, Sarman
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [34] Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women
    Sheu, M
    Hogan, J
    Allsworth, J
    Stein, M
    Vlahov, D
    Schoenbaum, EE
    Schuman, P
    Gardner, L
    Flanigan, T
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (08): : 743 - 750
  • [35] Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men
    Pinto, Ligia A.
    Wilkin, Timothy J.
    Kemp, Troy J.
    Abrahamsen, Martha
    Isaacs-Soriano, Kimberly
    Pan, Yuanji
    Webster-Cyriaque, Jennifer
    Palefsky, Joel M.
    Giuliano, Anna R.
    [J]. VACCINE, 2019, 37 (18) : 2502 - 2510
  • [36] Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults
    Riddell, James
    Brouwer, Andrew F.
    Walline, Heather M.
    Campredon, Lora P.
    Meza, Rafael
    Eisenberg, Marisa C.
    Andrus, Emily C.
    Delinger, Rachel L.
    Yost, Monica L.
    McCloskey, Jodi K.
    Thomas, Trey B.
    Huang, Suiyuan
    Ferris, Robert L.
    Shin, Dong Moon
    Fakhry, Carole
    Ow, Thomas
    Li, Daniel
    Berlot, Ashley
    Carey, Thomas E.
    Schlecht, Nicolas F.
    [J]. TUMOUR VIRUS RESEARCH, 2022, 13
  • [37] Refractory trichomoniasis in HIV-positive and HIV-negative subjects
    Miller M.R.
    Nyirjesy P.
    [J]. Current Infectious Disease Reports, 2011, 13 (6) : 595 - 603
  • [38] Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs
    Robbins, Hilary A.
    Fennell, Christina E.
    Gillison, Maura
    Xiao, Weihong
    Guo, Yingshi
    Wentz, Alicia
    Kirk, Gregory D.
    Mehta, Shruti H.
    D'Souza, Gypsyamber
    [J]. PLOS ONE, 2015, 10 (11):
  • [39] High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men
    Grabowski, Mary K.
    Gray, Ronald H.
    Serwadda, David
    Kigozi, Godfrey
    Gravitt, Patti E.
    Nalugoda, Fred
    Reynolds, Steven J.
    Wawer, Maria J.
    Watya, Stephen
    Quinn, Thomas C.
    Tobian, Aaron A. R.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2014, 90 (04) : 337 - 343
  • [40] Nutrition Status Among HIV-Positive and HIV-Negative Inpatients with Pulmonary Tuberculosis
    Lazzari, Tassia Kirchmann
    Forte, Gabriele Carra
    Silva, Denise Rossato
    [J]. NUTRITION IN CLINICAL PRACTICE, 2018, 33 (06) : 858 - 864